NCT06946316 Dairy vs Plant-based Beverages for Improving Bone Health During Exercise
| NCT ID | NCT06946316 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Saskatchewan |
| Condition | Osteoporosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2025-05-30 |
| Primary Completion | 2027-05-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2025-05-30 with a primary completion date of 2027-05-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will evaluate the effects of consuming dairy milk versus two plant-based beverages (pea-based, and almond-based) after resistance training sessions (3 times per week for 12 months) on bone properties (bone mineral density, bone geometry), body composition, strength, and functional performance in post-menopausal women and men 50y and older.
Eligibility Criteria
Inclusion Criteria: * Women need to be postmenopausal (no age limit) * Men need to be 50y or older Exclusion Criteria: * Taking medications that might affect bone * Conditions that might preclude participating in a resistance-training program (determined by the "Get Active Questionnaire"). * Planning 6 weeks of travel during the 12 month intervention period * Planning major surgery during the 12 month intervention period * Already strength training greater than 2 days per week for 30 minutes or longer per session * Allergies to ingredients in the beverages
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06946316 clinical trial?
This trial is open to participants of all sexes, studying Osteoporosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06946316 currently recruiting?
Yes, NCT06946316 is actively recruiting participants. Contact the research team at phil.chilibeck@usask.ca for enrollment information.
Where is the NCT06946316 trial being conducted?
This trial is being conducted at Saskatoon, Canada.
Who is sponsoring the NCT06946316 clinical trial?
NCT06946316 is sponsored by University of Saskatchewan. The trial plans to enroll 150 participants.